Thymectomy for Myasthenia Gravis: A 10-year Review of Cases at the Hospital Universiti Sains Malaysia
Main Article Content
Abstract
Background: A thymectomy is considered effective for patients with myasthenia gravis (MG). Although a few studies have described the role of a thymectomy in the treatment of MG in Asians countries, there are no published data on the application of this surgical approach for MG in Malaysia. We aimed to describe the clinical outcomes of MG patients who underwent a thymectomy and the factors affecting these outcomes. Methods: This was a retrospective study involving 16 patients with MG who underwent a thymectomy at the Hospital Universiti Sains Malaysia (HUSM) from January 2002 until December 2012, with a follow-up period ranging from 3–120 months. Results: The study consisted of 16 patients aged 22–78 years, 10 of whom were males. The overall remission/improvement rate was 87.5%, and the rate of clinical outcomes classified as unchanged/ worsened was 12.5%. Thymomamatous or non-thymomamatous MG, histology features, Osserman stage and the duration of follow-up were not significant prognostic factors. Post-operative mortality was 6.2% (1 of 16 patients died of septic shock). Conclusion: A thymectomy seems to be an effective treatment for MG, with low surgical morbidity. Patients with a lower Osserman stage and those with/without thymomas had favourable outcomes.
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976;26(11):1054– 1059. doi: http://dx.doi.org/10.1212/01.wnl.0000405029.20726.2c
Valli G, Jann S, Premoselli S, Scarlato G. Myasthenia gravis treatment: twelve years experience on 110 patients. Ital J Neurol Sci. 1987;8(6):593–601. doi: http://dx.doi.org/10.1007/bf02333667.
Osserman KE, Genkins G. Studies in Myasthenia Gravis. NY State J Med. 1961; 61: 2076–2085.
Blalock A, Mason MF, Morgan HJ, Riven SS. Myasthenia Gravis and tumors of the thymic region: Report of a case in which the tumor was removed. Ann Surg. 1939;110(4):544–561. doi: http://dx.doi.org/10.1097/00000658-193910000-00005.
Budde JM, Morris CD, Gal AA, Mansour KA, Miller JI Jr. Predictors of outcome in thymectomy for myasthenia gravis. Ann Thorac Surg. 2001;72(1):197–202.
Nussbaum MS, Rosenthal GJ, Samaha FJ, Grinvalsky HT, Quinlan JG, Schmerler M, et al. Management of myasthenia gravis by extended thymectomy with anterior mediastinal dissection. Surgery. 1992;112(4):681–688.
Lanska DJ. Indications for thymectomy in myasthenia gravis. Neurology. 1990;40(12):1828–1829. doi: http://dx.doi.org/10.1212/wnl.40.12.1828.
Nieto IP, Robledo JP, Pajuelo MC, Montes JA, Giron JG, Alonso JG, et al. Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases. Ann Thorac Surg. 1999;67(6): 1568–1571. doi: http://dx.doi.org/10.1016/s0003-4975(99)00310-0.
Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymectomy in myasthenia gravis. Results of 662 cases operated upon in 15 years. Eur J Cardiothorac Surg. 1989;3(6):504–511.
Stern LE, Nussbaum MS, Quinlan JG, Fischer JE. Long-term evaluation of extended thymectomy with anterior mediastinal dissection for myasthenia gravis. Surgery. 2001;130(4):774–780. doi: http://dx.doi.org/10.1067/msy.2001.116674.
Tellez-Zenteno JF, Remes-Troche JM, García-Ramos G, Estanol B, Garduno-Espinoza J. Prognostic factors of thymectomy in patients with myasthenia gravis: a cohort of 132 patients. Eur Neurol. 2001;46(4):171– 177. doi: http://dx.doi.org/10.1159/000050800.
Hsu HS, Huang CS, Huang BS, Lee HC, Kao KP, Hsu WH, Huang MH. Thymoma is associated with relapse of symptoms after transsternal thymectomy for myasthenia gravis. Interact Cardiovasc Thorac Surg. 2006;5(1):42–46. doi: http://dx.doi.org/10.1510/icvts.2005.116616.
Tsinzerling N, Lefvert AK, Matell G, PirskanenMatell R. Myasthenia gravis: a long term followup study of Swedish patients with specific reference to thymic histology. J Neurol Neurosurg Psychiatry.2007;78(10):1109–1112. doi: http://dx.doi.org10.1136/jnnp.2006.109488.
Masaoka A, Nagaoka Y, Kotake Y. Distribution of thymic tissue at the anterior mediastinum. Current procedures in thymectomy. J Thorac Cardiovasc Surg. 1975;70(4):747–754.
Masaoka A, Yamakawa Y, Niwa H, Fukai I, Kondo S, Kobayashi M, Fujii Y, Monden Y. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg. 1996;62(3):853–859. doi: http://dx.doi.org/10.1016/s0003-4975(96)00376-1.
Wright GM, Barnett S, Clarke CP. Video-assisted thoracoscopic thymectomy for myasthenia gravis. Intern Med J. 2002;32(8):367–371. doi: http://dx.doi.org/10.1046/j.1445-5994.2002.00251.x.
Ozdemir N, Kara M, Dikmen E, Nadir A, Akal M, Yucemen N, et al. Predictors of clinical outcome following extended thymectomy in myasthenia gravis. Eur J Cardiothorac Surg. 2003;23(2):233–237. doi: http://dx.doi.org/10.1016/s1010-7940(02)00744-3.
Venuta F, Rendina EA, De Giacomo T, Della Rocca G, Antonini G, Ciccone AM, et al. Thymectomy for myasthenia gravis: a 27-year experience. Eur J Cardiothorac Surg. 1999;15(5):621–625. doi: http://dx.doi.org/10.1016/s1010-7940(99)00052-4.
Gilbert ME, De Sousa EA, Savino PJ. Ocular Myasthenia Gravis treatment: the case against prednisone therapy and thymectomy. Arch Neurol. 2007;64(12):1790–1792.
Roberts PF, Venuta F, Rendina E, De Giacomo T, Coloni GF, Follette DM, et al. Thymectomy in the treatment of ocular myasthenia gravis. J Thorac Cardiovasc Surg. 2001;122(3):562–568. doi: http://dx.doi.org/10.1067/mtc.2001.116191.
Nakamura H, Taniguchi Y, Suzuki Y, Tanaka Y, Ishiguro K, Fukuda M, et al. Delayed remission after thymectomy for myasthenia gravis of the purely ocular type. J Thorac Cardiovasc Surg. 1996;112(2):371– 375. doi: http://dx.doi.org/10.1016/s0022-5223(96)70264-7.
Mussi A, Lucchi M, Murri L, Ricciardi R, Luchini L, Angeletti CA. Extended thymectomy in myasthenia gravis: a team-work of neurologist, thoracic surgeon and anaesthesist may improve the outcome. Eur J Cardiothorac Surg. 2001;19(5):570–575. doi: http://dx.doi.org/10.1016/s1010-7940(01)00634-0.
Remes-Troche JM, Tellez-Zenteno JF, Estanol B, Garduno-Espinoza J, Garcia-Ramos G. Thymectomy in myasthenia gravis: response, complications, and associated conditions. Arch Med Res. 2002;33(6):545–551.
Takanami I, Abiko T, Koizumi S. Therapeutic outcomes in thymectomied patients with myasthenia gravis. Ann Thorac Cardiovasc Surg. 2009;15(6):373–377.
Mantegazza R, Beghi E, Pareyson D, Antozzi C, Peluchetti D, Sghirlanzoni A, et al. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol. 1990;237(6): 339–344.doi: http://dx.doi.org/10.1007/bf00315656.